jmkx000189

Small moleculeexperimental

Clinical trial activity

5 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Sep 21, 2023 (NCT05967520)

Timeline

2020s

  1. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07242274Phase 3Dec 31, 2025Jemincare
NCT06946927Phase 1Jun 6, 2025Jemincare, Shantou University
NCT06473948Phase 1Jul 10, 2024Jemincare
NCT06348290Phase 1Apr 1, 2024Jemincare
NCT05967520Phase 2Sep 21, 2023Chinese Academy of Medical Sciences, Jemincare
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
JemincareFor profit5532023
Chinese Academy of Medical SciencesAcademic/Hospital1012023
Shantou UniversityAcademic/Hospital1012025
3 organizations
Page 1 / 1